We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gregory Jackson

Gregory R Jackson PhD

Chief Scientific Officer, MacuLogix, Inc., Hummelstown, PA

Gregory Jackson, PhD is an entrepreneurial scientist with clinical research expertise in the areas of age-related macular degeneration and diabetic retinopathy. He serves as Chief Scientific Officer for MacuLogix, Inc., a start-up medical diagnostic device company. He invented and commercialized the AdaptDx, diagnostic test and clinical research tool for age-related macular degeneration

Dr. Jackson has experience with technology transfer, intellectual property, clinical development plans, small business innovative research grants, product development, medical device quality systems, good clinical practice, 510K FDA medical device regulations, medical affairs, clinical trial design and management.

Disclosures

Dr. Jackson’s conflict of interest is his employment.  MacuLogix is the manufacturer of the AdaptDx, a dark adaptometer.